Aurobindo Pharma slips on buzz of its Unit 1 receives USFDA observations

22 Dec 2016 Evaluate

Aurobindo Pharma is currently trading at Rs. 663.70, down by 2.75 points or 0.41% from its previous closing of Rs. 666.45 on the BSE.

The scrip opened at Rs. 667.00 and has touched a high and low of Rs. 671.00 and Rs. 662.20 respectively. So far 43749 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 895.00 on 06-Oct-2016 and a 52 week low of Rs. 582.00 on 25-Feb-2016.

Last one week high and low of the scrip stood at Rs. 711.65 and Rs. 657.50 respectively. The current market cap of the company is Rs. 38896.22 crore.

The promoters holding in the company stood at 53.79%, while Institutions and Non-Institutions held 34.39% and 11.82% respectively.

The US Food and Drug Administration (USFDA) has reportedly issued Form 483 observations against Unit I of Aurobindo Pharma in Hyderabad, India. The plant is used for manufacturing of active pharmaceutical ingredients (APIs), which contribute little over 20% of the company's total revenues.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1263.00 63.25 (5.27%)
05-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1487.45
Dr. Reddys Lab 5822.90
Cipla 1497.85
Zydus Lifesciences 1049.75
Lupin 1630.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.